Skip to main content
Premium Trial:

Request an Annual Quote

John Cooke, William Hiatt, Joseph Coll, Eric Fung

Vermillion last week said it has formed a clinical steering committee to help it develop and commercialize a blood-based test for peripheral artery disease.
The committee will also provide scientific guidance to help the company get approval from the US Food and Drug Administration for the test under development by Vermillion, the company said in a statement.
The initial members of the committee are: John Cooke, a professor of medicine at Stanford University and immediate past-president of the Society for Vascular Medine and Biology; William Hiatt, president of the Colorado Prevention Center and professor of medicine and chief of vascular medicine at the University of Colorado Denver School of Medicine; Joseph Coll, senior biostatistician at the Colorado Prevention Center and assistant professor at the University of Colorado Denver School of Medicine; and Eric Fung, CSO of Vermillion.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.